CSIMarket
 


Champions Oncology Inc   (CSBR)
Other Ticker:  
 
 

Champions Oncology Inc Accounts Receivables Turnover Ratio from the third quarter 2024 to the third quarter 2023

Quarterly Results, Trends, Rankings, Statistics


Champions Oncology Inc 's ability to collect accounts receivable sequentially worsen to 6.04, indicating more challenging environment then in the second quarter 2024, but still, it is a far cry from any concerns. Average collection period, for Champions Oncology Inc 's accounts receivable remained unchanged at 60 days, in the Jan 31 2024 quarter.

If we take a look into Healthcare sector 13 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 181, from overall ranking in the second quarter 2024 at 382.

What is Receivable Turnover Ratio?
What is Champions Oncology Inc Selling?


What is Receivable Turnover Ratio?




CSBR Receivables Turnover Ratio (Jan 31 2024)
III. Quarter
(Oct 31 2023)
II. Quarter
(Jul 31 2023)
I. Quarter
(Apr 30 2023)
IV. Quarter
(Jan 31 2023)
III. Quarter
Y / Y Receivable Change -1.96 % -13.68 % -4.35 % -15.79 % -5.96 %
Y / Y Revenue Change -5.9 % -18.96 % -8.61 % 1.51 % -3.18 %
Receivable Turnover Ratio (TTM) 6.04 6.11 6.21 6.27 5.99
CSBR's Total Ranking # 181 # 382 # 2296 # 428 # 2298
Average receivable collection period 60 60 59 58 61
Seq. Receivable Change 2.21 % -13.68 % 11.7 % -0.52 % -10 %
Seq. Revenue Change 3.85 % -7.87 % -3.9 % 2.33 % -10.56 %


Receivable Turnover Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 1
Healthcare Sector # 14
Overall Market # 181

Receivable Turnover Ratio Statistics
High Average Low
2.88 1.85 1.14
(Apr 30 2018)   (March 31, 2014)






Financial Statements
Champions Oncology Inc 's Accounts Receivable $ 8 Millions Visit CSBR's Balance sheet
Champions Oncology Inc 's Sales TTM $ 49 Millions Visit CSBR's Income Statement
Where are CSBR's Sales coming from? Visit CSBR's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CSBR's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover
Accounts Receivable Turnover for CSBR's Competitors
Receivables Turnover Ratio for CSBR's Suppliers
Accounts Receivables Turnover Ratio for CSBR's Customers

You may also want to know
CSBR's Growth Rates CSBR's Roa CSBR's Inventory Turnover Ratio CSBR's Dividend Comparisons
CSBR's Profitability Ratios CSBR's Roi CSBR's Asset Turnover Ratio CSBR's Dividend Growth
CSBR's Valuation Ratios CSBR's Roe CSBR's Financial Strength Ratios CSBR's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jan 31 2024, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jan 31 2024 Receivable at quarter ending Jan 31 2024
Halozyme Therapeutics Inc   17.02 $ 829.253  Millions$ 48.721  Millions
Recursion Pharmaceuticals Inc   15.69 $ 44.575  Millions$ 2.842  Millions
Owens and Minor inc  15.24 $ 10,333.161  Millions$ 677.813  Millions
Neuroone Medical Technologies Corporation  14.87 $ 2.816  Millions$ 0.189  Millions
Chemed Corporation  14.52 $ 2,264.417  Millions$ 155.918  Millions
Icu Medical Inc  14.46 $ 2,259.126  Millions$ 156.262  Millions
Patterson Companies Inc   14.11 $ 6,565.239  Millions$ 465.318  Millions
Corcept Therapeutics Inc  13.70 $ 482.375  Millions$ 35.215  Millions
Theralink Technologies Inc   13.67 $ 0.511  Millions$ 0.037  Millions
Protalix Biotherapeutics inc   13.39 $ 65.494  Millions$ 4.890  Millions
Exact Sciences Corporation  13.25 $ 2,532.479  Millions$ 191.179  Millions
Utah Medical Products Inc  12.39 $ 50.658  Millions$ 4.088  Millions
Teladoc Health Inc   12.18 $ 2,602.415  Millions$ 213.613  Millions
Caribou Biosciences Inc   12.12 $ 34.477  Millions$ 2.844  Millions
Siga Technologies Inc  11.78 $ 139.917  Millions$ 11.881  Millions
Sunshine Biopharma Inc   11.49 $ 24.093  Millions$ 2.097  Millions
Integrated Biopharma Inc  11.42 $ 48.833  Millions$ 4.275  Millions
Option Care Health Inc   11.09 $ 4,302.223  Millions$ 388.081  Millions
National Research Corporation  11.05 $ 148.580  Millions$ 13.445  Millions
National Healthcare Corp  10.98 $ 1,141.544  Millions$ 104.011  Millions
Revance Therapeutics Inc   10.95 $ 234.040  Millions$ 21.377  Millions
Biontech Se  10.68 $ 4,277.280  Millions$ 400.624  Millions
Arrowhead Pharmaceuticals Inc   10.29 $ 181.740  Millions$ 17.670  Millions
Viemed Healthcare Inc   10.22 $ 183.008  Millions$ 17.905  Millions
Sophia Genetics Sa  10.15 $ 61.913  Millions$ 6.100  Millions
Lumos Pharma Inc   10.07 $ 2.051  Millions$ 0.204  Millions
Semler Scientific Inc   9.93 $ 68.184  Millions$ 6.867  Millions
United Therapeutics Corporation  9.85 $ 2,327.500  Millions$ 236.175  Millions
Xoma Corporation  9.74 $ 4.758  Millions$ 0.489  Millions
Eton Pharmaceuticals Inc   9.66 $ 31.061  Millions$ 3.216  Millions

Date modified: 2024-03-15T15:53:49+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com